Cargando…
The pharmacokinetics of high-dose methotrexate in people living with HIV on antiretroviral therapy
PURPOSE: Clinical outcomes for lymphoma in people living with HIV (PLWH) are similar to those in the general public. However, a number of concerns remain including pharmacological interactions between cytotoxic chemotherapy and antiretroviral therapy (ARVs). Much attention has focussed on pharmacoki...
Autores principales: | Dalla Pria, Alessia, Bendle, Maggie, Ramaswami, Ramya, Boffito, Marta, Bower, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767850/ https://www.ncbi.nlm.nih.gov/pubmed/26696583 http://dx.doi.org/10.1007/s00280-015-2940-3 |
Ejemplares similares
-
The exclusion of people living with HIV (PLWH) from clinical trials in lymphoma
por: Venturelli, Serena, et al.
Publicado: (2015) -
Blood Epstein–Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma
por: Ul-Haq, Ikram, et al.
Publicado: (2018) -
Implications of Bariatric Surgery on the Pharmacokinetics of Antiretrovirals in People Living with HIV
por: Zino, Leena, et al.
Publicado: (2022) -
Recent advances in HIV-associated Kaposi sarcoma
por: Dalla Pria, Alessia, et al.
Publicado: (2019) -
Changes in functional connectivity in people with HIV switching antiretroviral therapy
por: Toniolo, Sofia, et al.
Publicado: (2020)